Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin
暂无分享,去创建一个
S. Dalvie | R. Ramesar | T. Spracklen | A. Vorster | L. Ramma | S. Dalvie | Rajkumar Ramesar | Timothy F. Spracklen